Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SPESOLIMAB-SBZO for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 7 adverse event reports in the FDA FAERS database where SPESOLIMAB-SBZO was used for Psoriasis.

Most Reported Side Effects for SPESOLIMAB-SBZO

Side Effect Reports % Deaths Hosp.
Generalised pustular psoriasis 29 14.7% 1 3
Drug ineffective 20 10.1% 0 1
Rash 14 7.1% 0 1
Pruritus 13 6.6% 0 1
Fatigue 11 5.6% 0 0
Psoriasis 10 5.1% 0 2
Pustule 9 4.6% 0 0
Headache 7 3.5% 0 0
Urinary tract infection 7 3.5% 1 4
Arthralgia 6 3.0% 0 1
Condition aggravated 6 3.0% 0 0
Intentional product use issue 6 3.0% 0 0
Maternal exposure during pregnancy 6 3.0% 0 0
Off label use 6 3.0% 0 2
Peripheral swelling 6 3.0% 0 1

Other Indications for SPESOLIMAB-SBZO

Generalised pustular psoriasis (80) Pustular psoriasis (70) Product used for unknown indication (36)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

SPESOLIMAB-SBZO Full Profile All Psoriasis Drugs SPESOLIMAB-SBZO Demographics SPESOLIMAB-SBZO Timeline